Cardiff Oncology, Inc. - Common Stock (NQ: CRDF )
4.290
+0.140
(+3.37%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Press Releases about Cardiff Oncology, Inc. - Common Stock
![](https://www.financialnewsmedia.com/wp-content/uploads/2024/09/ONCY-banner-092024.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2024/09/ONCY-banner-092024.jpg)
Topics
Artificial Intelligence
![](https://ml.globenewswire.com/media/f326183f-8829-42af-8851-525b1d7503ed/small/finacialnews-logo-final-01-2-png.png)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Via GlobeNewswire
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies
November 07, 2022
Exposures
COVID-19
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028
October 12, 2022
Exposures
COVID-19
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free